Atai Life Sciences Cash Flow from Investing Activities 2020-2024 | ATAI
Atai Life Sciences cash flow from investing activities from 2020 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
| Atai Life Sciences Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2024 | $59 |
| 2023 | $-53 |
| 2022 | $-87 |
| 2021 | $-81 |
| 2020 | $-28 |
| 2019 | $-9 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.280B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $19.637B | 19.35 |
| Encompass Health (EHC) | United States | $11.683B | 24.77 |
| DaVita (DVA) | United States | $11.040B | 14.66 |
| Chemed (CHE) | United States | $8.325B | 26.16 |
| Elanco Animal Health (ELAN) | United States | $6.099B | 13.06 |
| Option Care Health (OPCH) | United States | $5.191B | 23.14 |
| RadNet (RDNT) | United States | $4.229B | 89.49 |
| Amedisys (AMED) | United States | $3.124B | 21.01 |
| LifeStance Health (LFST) | United States | $2.259B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.037B | 22.36 |
| Astrana Health (ASTH) | United States | $1.875B | 46.44 |
| U.S Physical Therapy (USPH) | United States | $1.077B | 27.81 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.073B | 61.11 |
| Pennant (PNTG) | United States | $0.971B | 35.66 |
| Daxor (DXR) | United States | $0.037B | 0.00 |
| Ontrak (OTRK) | United States | $0.007B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.005B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |